Video

Dr. Goy on the Results of the FLYER Trial in DLBCL

Author(s):

Andre Goy, MD, MS

In Partnership With:

Andre Goy, MD, MS, chief, discusses the results of the multicenter FLYER trial in patients with diffuse large B-cell lymphoma.

Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses the results of the multicenter FLYER trial in patients with diffuse large B-cell lymphoma.

Related Videos
Julia Foldi, MD, PhD
Joaquim Bellmunt, MD, PhD
Brandon Huffman, MD
Sattva S. Neelapu, MD
Julie M. Vose, MD, MBA
Lakshmi Nayak, MD
John Burke, MD
Justin M. Watts, MD
Rohan Garje, MD
Manmeet Ahluwalia, MD, MBA, FASCO
Related Content
Kathleen A. Dorritie, MD, of University of Pittsburgh Medical Center Hillman Cancer Center​
June 11th 2024

Long-Term Data for Up-Front Combinations Reaffirm Treatment Options in CLL

Andre H. Goy, MD, vice president, physician in chief, Oncology Care Transformation Services, chairman, chief physician officer, chief, Lymphoma Division, John Theurer Cancer Center at Hackensack University Medical Center; Lydia Pfund Chair for Lymphoma, academic chairman, Oncology, Hackensack Meridian School of Medicine; professor, medicine, Georgetown University
May 6th 2024

Goy Gives Insights Into the Future Management of Lymphoma and Multiple Myeloma

Angelos Stergiou, MD, ScD hc
June 10th 2024

CDK9 Inhibitor SLS009 Displays Activity in Relapsed/Refractory AML

OncLive On Air
March 18th 2024

Revisit the OncLive On Air Episodes From February 2024

Eunice S. Wang, MD
June 6th 2024

Wang Expands on the Continued Investigation of Targeted Therapies in Relapsed/Refractory AML

Mark Frattini, MD, PhD
June 5th 2024

UCART22 Earns Orphan Drug Designation for Acute Lymphoblastic Leukemia in Europe